2 citations
,
January 2020 in “Journal of Pharmacognosy and Phytochemistry” This article reviews the medicinal significance of the Eclipta alba plant in India and its therapeutic properties, but reports no new clinical results.
January 2025 in “Journal of Education Health and Sport” This study reviewed existing methods to prevent chemotherapy-induced hair loss, highlighting FDA-approved scalp cooling as currently the most effective yet still insufficient solution and noting the need for more reliable treatments to better support cancer patients.
January 2026 in “International Journal of Science and Research Methodology” This review explored the therapeutic potential of Bhangra (Eclipta alba) for treating premature greying of hair, noting the plant's melanogenic, antioxidant, and revitalizing properties, but highlighted the need for further research to scientifically support its effectiveness.
July 2026 in “Current Pharmaceutical Design” This review highlights the therapeutic potential of medicinal plants, such as Eclipta alba and Ginkgo biloba, for managing alopecia through various molecular mechanisms, but stresses the need for further clinical trials to confirm their safety and efficacy as alternatives to synthetic treatments.
222 citations
,
January 2021 in “Phytomedicine Plus” This review discusses the key Indian medicinal plants and their pharmacological properties, aiming to support the development of new ethnomedicines, but it reports no new clinical results.